Individual results vary some lose more, some less
Our existing BPC-157 dosage discussion should be read as educational context, not as a protocol produced or endorsed by the July committee
Accordingly, efforts to lower cholesterol to mitigate cardiovascular risk should be paired with measures to reduce other risk factors such as inflammation, oxidation, hypertension, excess plasma glucose, excess body weight, excess fibrinogen, excess homocysteine, low vitamin K, insufficient vitamin D, hormone imbalance, etc
Unknown Systemic Effects : Potential for unforeseen effects on other organ systems due to systemic exposure, especially with injectable forms
The 10 mg lyophilized format allows precise dosing and reproducible outcomes in research protocols